News Releases & Research Results Commercialization of single-cell RNA sequencing kits ―Contributes to the promotion of genomic medicine―

2019.9.17News Releases & Research Results

Outline

Results of research and development by a research team of Technical Scientist Tetsutaro Hayashi, Team Leader Itoshi Nikaido, and others of the Laboratory for Bioinformatics Research, RIKEN Center for Biosystems Dynamics Research.

Key points of the R&D results

  • "A full-length total RNA sequencing of single cells (RamDA-seqTM)" was developed, which can overcome some challenges associated with the conventional genetic analysis methods (e.g., full-length sequencing is not possible, mutations that cause diseases cannot be determined completely).
  • This method has made it possible to detect the full length, etc. of RNA, enabling measurements of genes and mutations, unlike existing methods.
  • This is expected to contribute to genomic diagnostics including all genes for cancers in which mutations in gene sequences occur.
  • By licensing out to Toyobo Co., Ltd., "GenNext® RamDA-seqTM Single Cell Kit" and "RT-RamDATM cDNA synthesis Kit" have been commercialized.

This research and development was conducted with the support of Platform Project for Supporting Drug Discovery and Life Science Research by AMED.

Last updated 2019.9.17